References
Sehgal SN, Molnar-Kimber KL, Ocain TD, Weichman BM. Rapamycin: a novel immunosuppressive macrolide. Med Res Rev 1994;14:1–22.
Chen Y, Chen H, Rhoad AE, Warner LM, Caggiano TJ, Failli A, et al. Isolation of a sirolimus (rapamycin) effector protein. Biochem Biophys Res Com 1994;203:1–7.
Brown EJ, Albers MW, Shin TB, Ichikawa K, Keltis CT, Lane WS, et al. A mammalian protein targeted by G2-arresting rapamycin receptor complex. Nature 1994;369:756–8.
Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SN. RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 1994;78:35–43.
Dumont FJ, Altmeyer A, Kastner C, Fischer PA, Lemon KP, Chung J, et al. Relationship between multiple biologic effects of rapamycin and the inhibition of pp70S6 protein kinase activity. J Immunol 1994;152:992–1003.
Ocain TD, Longhi D, Steffan RJ, Caccese RG, Sehgal SN. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase. Biochem Biophys Res Commun 1993;192:1340–6.
Bierer BE, Somers PK, Wandless TJ, Burakoff SJ, Schreiber SL. Probing immunosuppressant action with a nonnatural immunophilin ligand. Science 1990;250:556–9.
Dumont FJ, Staruch MJ, Koprak SL, Siekierka JJ, Lin CS, Harrison R, et al. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J Exp Med 1992;176:751–60.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Molnar-Kimber, K.L., Rhoad, A., Warner, L. et al. Comparison of effects of sirolimus on cytokine dependent and cytokine independent proliferation. Inflamm Res 44 (Suppl 2), S189–S190 (1995). https://doi.org/10.1007/BF01778325
Issue Date:
DOI: https://doi.org/10.1007/BF01778325